ScienceFlashTalk

The SSPH+ ScienceFlashTalk promotes exciting and engaging speed-talks about public health research of SSPH+ PhD students. The aim is strengthening students’ skills to communicate their research to a broad audience. Highlight of the training is the public competition for a SSPH+ ScienceFlashTalk award.

Eligible PhD students receive a speed-talk training and coaching with communication experts and compete in a SSPH+ ScienceFlashTalk event.

ScienceFlashTalk 2018

18 PhD students are trained in speed-talking and will compete at one of the three following events where the audience is the jury:

ECTS: 1

Similar national events

SSPH+ ScienceFlashTalk Winners

  • Bonaventure convinced the GHF audience with his 3-minute flash talk on "Does Sickle Cell Disease Knowledge deficits influence reported painful episodes in adolescents and adults with Sickle Cell Disease?" Sickle Cell Disease (SCD) is a common form of blood disorder predominantly found in Africa, India and people of African descent. People with SCD often suffer from different complications such as gall stones and painful episodes leading to frequent hospital admissions. Recent findings suggest that knowledge deficit in SCD is an important indicator of health outcomes. Bonaventure's study seeks to assess levels of knowledge deficit in parents of children, identify factors that influence knowledge and whether knowledge levels influence reported painful crises episodes.

  • Winner 2017

    Kateryna Chepynoga

    Kateryna Chepynoga, PhD student at HEC Lausanne and supervised by SSPH+ Fellow Jürgen Maurer (HEC Lausanne) and Gabriela Flores (WHO), has won the 1st SSPH+ ScienceFlashTalk Award in Lugano on 9 June 2017. The award has been sponsored by the Swiss Academy of Medical Sciences.

    Watch her flash talk

  • Kateryna convinced the SSPH+ faculty with her 3-minute flash talk on "Drivers of not affordable medication for chronic diseases in low- and lower-middle-income countries". Patients of low- and lower-middle-income countries are often not financially protected from health expenditures and purchase medicines out-of-pocket. By decomposing prices of drugs into components (cost of the procurement and mark-ups) Kateryna identifies what makes medicine prices to be not affordable. In particular, she detects price components, which most frequently push patients with chronic diseases into poverty, and estimates to what extent the price regulation policy, applied to these components, may improve the affordability of medicines.